Pharmacy Asks Court To Toss Novo Nordisk Semaglutide Suit
A pharmacy asked a Texas federal judge to toss claims brought by Novo Nordisk Inc. accusing the pharmacy of illicitly compounding a lucrative weight-loss drug called semaglutide, saying Novo Nordisk's complaint...To view the full article, register now.
Already a subscriber? Click here to view full article